Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Endonovo Therapeutics Inc (ENDV)

Endonovo Therapeutics Inc (ENDV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Endonovo Therapeutics Appoints Dr. William Li as Strategic Advisor to the CEO

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announces it has appointed Dr. William Li as Strategic Advisor to the CEO. Dr. Li and Endonovo CEO Alan Collier will work collaboratively...

ENDV : 0.0090 (-5.26%)
Endonovo Partners with Veterans Healthcare Supply Solutions, Appoints Samir Awad, M.D., to Scientific Advisory Board

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of noninvasive Electroceutical(R) therapeutic devices, today announces a partnership with Veterans...

ENDV : 0.0090 (-5.26%)
Endonovo Therapeutics Appoints Dr. Geoffrey Abrams of Stanford University to Its Scientific Advisory Board

via NetworkWire -- Endonovo Therapeutics Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of noninvasive Electroceutical therapeutic devices, today announces the appointment...

ENDV : 0.0090 (-5.26%)
Endonovo Therapeutics Announces Second Quarter Results

via NetworkWire - Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), today announces financial and operating results for the second quarter ended June 30, 2019.

ENDV : 0.0090 (-5.26%)
Endonovo Therapeutics Inc. Featured in Exclusive NetworkNewsWire Broadcast

via NetworkNewsAudio - Endonovo Therapeutics Inc. (OTCQB: ENDV), an innovative biotechnology company and commercial-stage developer of noninvasive Electroceutical(TM) therapeutic devices, today announces...

ENDV : 0.0090 (-5.26%)
Endonovo Therapeutics Appoints Dr. Peter Novak to its Scientific Advisory Board

via NetworkWire -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of noninvasive Electroceutical(TM) therapeutic devices, today announces the appointment...

ENDV : 0.0090 (-5.26%)
Endonovo Therapeutics Appoints Dr. Steven Levin of Johns Hopkins University to Its Scientific Advisory Board

via NetworkWire - Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical(TM) therapeutic devices, today announces the appointment...

ENDV : 0.0090 (-5.26%)
Coverage Initiated for Endonovo Therapeutics via NetworkNewsWire

via NetworkWire -- Endonovo Therapeutics (OTCQB: ENDV), an innovative biotechnology company developing a bioelectronic approach to regenerative medicine, today announces it has selected the corporate communications...

ENDV : 0.0090 (-5.26%)
Guitar Center, Inc. Announces Early Tender Results for Its Previously Announced Exchange Offer and Consent Solicitation Relating to Its 9.625% Senior Unsecured Notes Due 2020

Guitar Center, Inc. (the "Company") announced the early tender results for its previously announced exchange offer and consent solicitation (the "Exchange Offer") to (i) exchange its existing 9.625% Senior...

Endonovo Therapeutics Appoints Dr. Roc Alan McCarthy as a Scientific Advisory Board Member

Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced, that Roc Alan McCarthy, D.O. will be joining the company as a Scientific Advisory Board Member. Dr. McCarthy will help Endonovo continue to advance...

ENDV : 0.0090 (-5.26%)
Endonovo Therapeutics Announces Steven Ford as V.P. Marketing

Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced, Steven Ford will be joining the company as Vice President of Marketing. In his position, Mr. Ford will be responsible for growing Endonovo's...

AGN : 173.60 (+0.64%)
ENDV : 0.0090 (-5.26%)
Endonovo Therapeutics Hires David Clark as Vice President of Sales

Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced veteran sales leader David Clark joined as Endonovo's Vice President of Sales. In his new position, Mr. Clark will lead the U.S. Sales Team, distributors...

MDT : 108.12 (-0.36%)
ENDV : 0.0090 (-5.26%)
Endonovo Therapeutics Hires Nevena Zubcevik of Harvard Medical School as Chief Medical Officer

Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced the appointment of Nevena Zubcevik, DO, MSPT, ATC as its chief medical officer starting July 1, 2019.

ENDV : 0.0090 (-5.26%)
Endonovo Therapeutics Provides Corporate Update

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical(TM) therapeutic devices, today announced a corporate update and business...

ENDV : 0.0090 (-5.26%)
Endonovo Therapeutics Announces Partnership with Second Hospital

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), today announced an agreement with a nationally recognized hospital group to enhance the quality of the healthcare/patient experience...

ENDV : 0.0090 (-5.26%)
Endonovo Therapeutics Granted Trademarks for WoundPulse and OrthoHalo

March 22, 2019 -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical(TM) therapies brand, today announced the U.S. Patent...

ENDV : 0.0090 (-5.26%)
Endonovo Therapeutics Partners with SunMED Medical Systems

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"),

MDSY : 0.73 (+4.29%)
ENDV : 0.0090 (-5.26%)
Endonovo Therapeutics Announces New Website Launch

The completely redesigned website offers visitors deeper insight into the Company's core product, SofPulse(R)

ENDV : 0.0090 (-5.26%)
Endonovo Therapeutics Files Lawsuit against KVP International Inc., Orthocor Medical Inc., and Careus Corp. for Patent Infringement

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical(TM) therapeutic devices, filed a patent infringement lawsuit today...

ENDV : 0.0090 (-5.26%)
Innovative Developments in Biotechnology set to Spur the Market Growth

NEW YORK, January 23, 2019 /PRNewswire/ --

SNET : 0.0103 (+63.49%)
NMUS : 0.6500 (-9.52%)
ATBPF : 0.3280 (+4.26%)
PMCB : 0.0358 (unch)
ENDV : 0.0090 (-5.26%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI +4.48 , AIZ -0.27 , SBAC +4.06 , SO +0.08 , WELL +0.91
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar